BHVN: Biohaven Ltd

BHVN新闻

• 16:11 Biohaven通过战略性小野协议扩大亚洲授权版图
• 16:11 Biohaven Expands Asian Licensing Footprint Through Strategic Ono Agreement
• 08:12 Biohaven Licenses MoDE IgG Degraders To Ono For Japan, South Korea, Taiwan And ASEAN For Up To $100M Near-Term Payments Including $80M Upfront; BHV-1300 In Phase 3 For Graves' Disease
• 11:49 Biohaven To Present Data On BHV-1530, FGFR3-Directed ADC Using Topoisomerase I Payload, At 38th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics
• 17:30 Warby Parker’s Unusual Options Activity Points to a Covered Call Bet: Bullish on Growth, Cautious on Valuation
• 12:01 Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
• 12:01 星期五盘前交易中，氙气制药、钢铁动力、纽科尔等大型股票走低
• 08:25 为什么Alaunos Therapeutics股票交易价上涨约22％？这里有20只股票正在盘前交易
• 08:25 Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
• 21:17 Biohaven: The Hold Isn't The Problem (Rating Downgrade) (NYSE:BHVN)
• 13:36 Biohaven Plummets, A Boon For Rival Xenon, On A Surprise Seizure Setback